“On August 17, 2021, we submitted an software to the Central Medication Customary Management Organisation (CDSCO) to conduct a examine of the Johnson & Johnson Covid-19 vaccine in India in adolescents aged 12-17 years,” a J&J India spokesperson mentioned in an announcement.
To finally obtain herd immunity, it’s crucial that Covid-19 vaccine scientific trials proceed to maneuver ahead on this inhabitants, the spokesperson added. “We stay deeply dedicated to the important work wanted to make our vaccine equitably accessible for all age teams,” the corporate spokesperson famous.
Earlier this month, the federal government had given Emergency Use approval to J&J’s single-dose Covid vaccine in India. Whereas saying the approval, well being minister Mansukh Mandaviya had mentioned the approval would additional enhance the nation’s collective struggle in opposition to the novel coronavirus an infection.
The 5 vaccines granted Emergency Use Authorisation in India are Covishield, Covaxin, Sputnik V, Moderna and J&J. PTI